Browsing Tag
New York
281 posts
Can HCLTech turn Red Hat’s open-source AI stack into an enterprise growth lever?
HCLTech and Red Hat are targeting enterprise AI infrastructure as companies scale beyond pilots. Find out what this means for AI adoption today!
Accenture backs Aera Technology as enterprises race toward autonomous supply chains
Find out how Accenture’s Aera Technology investment could reshape AI-enabled supply chains, decision intelligence and enterprise automation.
TradeZero expands active-trader infrastructure with execution-first API for stocks, options and short selling
TradeZero is turning short locates into code. See how its new API could reshape active trading workflows and broker competition.
Why DayOne’s $5bn IPO plan could become Singapore’s biggest capital-market test in years
AI needs data centres, but capital needs liquidity. DayOne’s planned dual listing could test Singapore’s Nasdaq bridge at scale.
Muscle Milk just changed its formula, but PepsiCo may be chasing something much bigger
Protein is booming, but consumers are confused. PepsiCo’s Muscle Milk reset turns simplicity into a new functional beverage strategy.
Long Island Rail Road strike shuts down New York commuter service after contract talks collapse
New York’s busiest commuter rail link is down. The Long Island Rail Road strike now tests wages, fares and weekday mobility.
SAP (NYSE: SAP) bets €1bn on Prior Labs and Dremio as enterprise AI strategy widens
SAP is spending over €1 billion to build a European frontier AI lab. The harder question is whether tabular models can outflank Microsoft and Snowflake.
Iran War Powers vote fails 47 to 50 one day before May 1 statutory deadline expires
Senate rejected the sixth Iran War Powers Resolution 47 to 50 on April 30. The 60-day statutory deadline arrives Friday, with Trump's legal authority unresolved.
Lilly bets up to $2.3bn on Ajax Therapeutics to crack the resistant myelofibrosis market with a Type II JAK2 inhibitor
Lilly is paying up to $2.3B for Ajax Therapeutics' Type II JAK2 inhibitor. The real question is whether it can crack Incyte's Jakafi grip on myelofibrosis.
Origami Risk wins Gramercy Risk Management mandate for full P&C platform rollout
Specialty insurers need scale without chaos. Gramercy’s Origami Risk deal shows why core insurance software is becoming a growth weapon.